| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $10K | +100.0% |
| R&D Expense | $362K | -97.8% |
| SG&A Expense | $4.5M | -63.5% |
| Operating Income | -$4.8M | +86.0% |
| Interest Expense | $1.9M | -1.1% |
| Net Income | -$4.7M | +86.7% |
| EPS (Basic) | -$2.92 | -32.7% |
| EPS (Diluted) | -$2.92 | -32.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.1M | -82.0% |
| Accounts Receivable | $5K | +400.0% |
| Current Assets | $2.8M | -66.7% |
| Total Assets | $2.8M | -66.7% |
| Current Liabilities | $692K | -64.6% |
| Long-term Debt | $0 | — |
| Total Liabilities | $692K | -64.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$5.0M | +83.5% |
| Capital Expenditures | $0 | -100.0% |
| Investing Cash Flow | $0 | -100.0% |
| Financing Cash Flow | $0 | +100.0% |
| Free Cash Flow | -$5.0M | +83.6% |
| Stockholders' Equity |
| $2.1M |
| -67.3% |